Long Ideas

Aegis Initiates a Buy on Facebook Inc (FB); Sees 29% Upside for the Stock

Aegis analyst Victor Anthony is out today with a positive research report on shares of Facebook Inc (NASDAQ:FB). The analyst initiated coverage on …

Cantor Sees CAPB Advantage for Paratek Pharmaceuticals Inc (PRTK) in Wake of Cempra Inc (CEMP) CRL Setback

Cantor analyst Chiara Russo is liking the odds for Paratek Pharmaceuticals Inc (NASDAQ:PRTK) after Cempra Inc (NASDAQ:CEMP) received a Complete Response Letter (CRL) …

Chardan Bullish on AveXis Inc (AVXS) Following Rival Spinraza Broad-Label Approval

Chardan analyst Gbola Amusa is placing his confidence behind AveXis Inc (NASDAQ:AVXS) even in light of competitors Biogen Inc (NASDAQ:BIIB) and Ionis Pharmaceuticals …

Apple Inc (AAPL), salesforce.com, inc. (CRM): Drexel Hamilton’s Top IT Hardware and Software Picks for 2017

Wrapping up 2016, Drexel Hamilton analyst Brian White highlights his top picks for IT hardware and software for the coming new year. From …

Here’s Why This Benchmark Analyst Stays on the Sidelines on Pegasystems Inc. (PEGA)

For now, Benchmark analyst Mark Schappel is staying on the sidelines, reiterating a Hold rating on Pegasystems Inc. (NASDAQ: PEGA).

Trump Will Be Good for Booz Allen Hamilton Holding Corporation (BAH), Says Drexel Hamilton Analyst

The Trump administration is good news for Booz Allen Hamilton Holding Corporation (NYSE: BAH), opines Drexel Hamilton analyst Brian Ruttenbur, who reiterated a Buy rating …

FBR Chimes in on Ballard Power Systems Inc. (USA) (BLDP) Following Joint Venture Agreement with Guangdong Synergy Hydrogen

On December 22nd, Ballard Power Systems Inc. (USA) (NASDAQ:BLDP) offered a progress update on its partnership with local Chinese partner, Guangdong Synergy Hydrogen, …

Needham Bullish on Aerie Pharmaceuticals Inc (AERI) Despite NDA Filing Delay for Rhopressa

Needham’s Serge Belanger has reiterated his Buy rating on Aerie Pharma (NASDAQ: AERI) despite a stalled manufacturing pre-inspection that has caused the firm to delay …

Here’s Why Canaccord Sings the Praises of Synergy Pharmaceuticals Inc (SGYP); Shares Rise 5%

After market-close yesterday, Synergy Pharmaceuticals Inc (NASDAQ:SGYP) released positive second Phase 3 results for plecanatide, the firm’s pipeline daily pill designed to treat …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts